An improvement to the macro outlook on a COVID-19 vaccine could hurt the appraisals, if not the profits, of tech services, according to analysts.
Read More
Pfizer vaccine threatens tech’s outperformance – The Australian Financial Review
Byindianadmin
Nov 10, 2020